Advertisement
Advertisement

CDXS

CDXS logo

Codexis, Inc.

2.85
USD
Sponsored
+0.27
+10.47%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

2.85

0.00
-0.14%

Codexis, Inc. Profile

About

Codexis is a leading protein engineering company that applies its proprietary CodeEvolver technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis? proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes.

Info & Links

CEO

Alison Moore

Headquarters

200 PENOBSCOT DRIVE
REDWOOD CITY, CA 94063, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.codexis.com

Auditor

KPMG LLP

Share holders

113

Employees

146

Codexis, Inc. Statistics

Valuation Measures

Market Capitalization2

258.69M

Enterprise Value

262.18M

Enterprise Value/EBITDA(ttm)

-12.01

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

3.10

Price to Book(mrq)

4.29

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

79.05%

Operating Margin(ttm)

-62.47%

Profit Margin(ttm)

-141.06%

Return on Equity(ttm)

-90.51%

Return on Invested Capital(ttm)

-54.69%

Return on Assets(ttm)

-32.64%

Income Statement

Revenue(ttm)

78.09M

Revenue Per Share(ttm)

0.86

Gross Profit(ttm)

69.42M

EBITDA(ttm)3

-21.83M

Net Income Available to Common(ttm)

-31.99M

Diluted EPS(ttm)

-0.52

Share Statistics

Beta (5Y Monthly)

2.08

52-Week Change

15.85%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

90.90M

Dividend Yield

0.00%

Float4

89.14M

% Held by Insiders

1.90%

% Held by Institutions

78.54%

Balance Sheet

Total Cash(mrq)

65.56M

Total Cash Per Share(mrq)

0.72

Total Debt(mrq)

40.48M

Total Debt/Equity(mrq)

79.37%

Current Ratio(mrq)

3.82%

Quick Ratio(mrq)

3.75%

Book Value Per Share(mrq)

0.56

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.22

Free Cash Flow(ytd)

-23.84M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement